Corporate Glenmark Pharmaceuticals Limited March 21, 2026 Glenmark Pharmaceuticals Launches GLIPIQⓇ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly treatment starting at ₹325. |SUBJECT: Press Release Post navigation Poonawalla Fincorp Limited Poonawalla Fincorp Limited Related Posts Grill Splendour Services Limited Grill Splendour Services Limited has informed the Exchange regarding Outcome of Board Meeting held on… March 16, 2026 Indian Renewable Energy Development Agency Limited Chapter VIII – Specifications related to ISIN for debt |SUBJECT: Chapter VIII – Specifications related… April 15, 2026 Krishival Foods Limited Disclosure under regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations,… March 14, 2026 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Grill Splendour Services Limited Grill Splendour Services Limited has informed the Exchange regarding Outcome of Board Meeting held on… March 16, 2026
Indian Renewable Energy Development Agency Limited Chapter VIII – Specifications related to ISIN for debt |SUBJECT: Chapter VIII – Specifications related… April 15, 2026
Krishival Foods Limited Disclosure under regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations,… March 14, 2026
